Back
Plus Therapeutics Stock Price Chart
Sponsored
PSTV
Sponsored
Wall St Issues Rare "SELL" alert
MarketBeat is making the full list completely FREE for a limited time.
Sell
21
PSTV
Plus Therapeutics
Last Price:
1.80
Seasonality Move:
-12.69%
7 Day Trial
ALL ACCESS PASS
$
7
Do you own any of the "SELL" rated stocks on this list?
Go here now to get free instant access to all 20 stocks to sell.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PSTV is experiencing buying pressure, which is a positive indicator for future bullish movement.
Plus Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.61 | Buy |
20-day SMA: | 1.5 | Buy |
50-day SMA: | 1.55 | Buy |
200-day SMA: | 1.83 | Buy |
8-day EMA: | 1.61 | Buy |
20-day EMA: | 1.55 | Buy |
50-day EMA: | 1.57 | Buy |
200-day EMA: | 1.93 | Sell |
Plus Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.04 | Buy |
Relative Strength Index (14 RSI): | 67.97 | Buy |
Chaikin Money Flow: | 199360 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.35 - 1.61) | Buy |
Bollinger Bands (100): | (1.45 - 2.09) | Buy |
Plus Therapeutics Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Plus Therapeutics Stock
Is Plus Therapeutics Stock a Buy?
- Plus Therapeutics share price is 1.85 while PSTV 8-day simple moving average is 1.61, which is a Buy signal.
- The stock price of PSTV is 1.85 while Plus Therapeutics 20-day SMA is 1.50, which makes it a Buy.
- Plus Therapeutics 50-day simple moving average is 1.55 while PSTV share price is 1.85, making it a Buy technically.
- PSTV stock price is 1.85 and Plus Therapeutics 200-day simple moving average is 1.83, creating a Buy signal.
PSTV Technical Analysis vs Fundamental Analysis
Sell
21
Plus Therapeutics (PSTV)
is a Sell
Is Plus Therapeutics a Buy or a Sell?
-
Plus Therapeutics stock is rated a Sell
The current Plus Therapeutics [PSTV] share price is $1.85. The Score for PSTV is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
Plus Therapeutics Stock Info
Market Cap:
10.91M
Price in USD:
1.85
Share Volume:
370.24K
Plus Therapeutics 52-Week Range
52-Week High:
2.78
52-Week Low:
0.97
Sell
21
Plus Therapeutics (PSTV)
is a Sell
Plus Therapeutics Share Price Forecast
-
What is the Plus Therapeutics stock price today?
The Plus Therapeutics stock price is 1.85 USD today. -
Will PSTV stock go up or go down?
Plus Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Plus Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Plus Therapeutics is overvalued.
Is Plus Therapeutics Stock a Buy?
- Plus Therapeutics share price is 1.85 while PSTV 8-day exponential moving average is 1.61, which is a Buy signal.
- The stock price of PSTV is 1.85 while Plus Therapeutics 20-day EMA is 1.55, which makes it a Buy.
- Plus Therapeutics 50-day exponential moving average is 1.57 while PSTV share price is 1.85, making it a Buy technically.
- PSTV stock price is 1.85 and Plus Therapeutics 200-day simple moving average is 1.93, creating a Sell signal.
Fundamental Analysis of Plus Therapeutics
Is Plus Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.61 per share, an increase next quarter of $0.02 per share, an increase this year of $2.64 per share, and an increase next year of $0.17 per share.
Technical Analysis of Plus Therapeutics
Should I short Plus Therapeutics stock?
- PSTV Moving Average Covergence Divergence (MACD) indicator is 0.04, suggesting Plus Therapeutics is a Buy
- Plus Therapeutics Relative Strength Index (RSI) is 67.97, which suggest Plus Therapeutics is overbought
- The Bollinger Bands (25) for Plus Therapeutics is (1.35 - 1.61), which suggest Plus Therapeutics is a Buy
- The Bollinger Bands (100) for Plus Therapeutics is (1.45 - 2.09), which suggest Plus Therapeutics is a Buy
* Plus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.